- Vol 43, Issue 7
Schizophrenia and Psychosis Following Traumatic Brain Injury: Insights from Ting-Yi Chu, MD
Key Takeaways
- Prior TBI should be treated as a major psychiatric risk factor in history-taking for new-onset psychosis, including remote concussions that were not clinically tracked after acute recovery.
- Subgroup findings suggest higher psychosis association in adults (OR 2.99) versus minors (OR 1.25), implying delayed presentations after pediatric TBI may be missed without extended follow-up.
Meta-analysis links traumatic brain injury to rising long-term psychosis risk; severity, age, and follow-up time guide smarter screening and care.
An estimated 69 million individuals suffer all-cause traumatic brain injury (TBI) each year worldwide.1 Brain injury has known psychiatric consequences, and a new meta-analysis showed significant association between TBI and development of psychosis or schizophrenia. Further subgroup analysis showed increased risk across sex and age, with highest psychosis risk among adults and moderate-to-severe TBI cases.2 Psychiatric Times sat down with physician and lead investigator of the analysis, Ting-Yi Chu, MD, to learn more.
Psychiatric Times: What background indicated that there may be a relationship between TBI and schizophrenia/psychosis?
Ting-Yi Chu, MD: The inspiration for this study grew out of a clinical observation rather than a purely academic question. In geriatric medicine and public health, we frequently emphasize fall prevention in the elderly because of the risk of traumatic brain injury. It struck me that aging, dementia, and TBI all independently contribute to cognitive decline, and when these factors converge in the same patient, the clinical picture becomes remarkably complex.
This overlap raised a question in my mind: could TBI itself serve as a risk factor for schizophrenia or other psychotic disorders, distinct from the cognitive decline we typically attribute to aging or dementia?This question felt particularly urgent because if these conditions are being conflated or underrecognized, a meaningful proportion of TBI patients with emerging psychosis may be falling through diagnostic cracks.
From a scientific standpoint, no clear dose-response relationship between TBI severity and psychosis risk had been established, and demographic and clinical modifiers such as age, sex, and follow-up duration had not been systematically examined. We used both odds ratios and hazard ratios in our analysis—one captures cumulative risk, the other captures how risk unfolds over time.
PT: How can psychiatric clinicians utilize your findings to inform their practice?
Chu: The most immediate takeaway is that TBI should be treated as a relevant risk factor in the psychiatric history, much like family history or substance use. When a patient presents with new-onset psychotic symptoms, asking about prior head injuries, including concussions that may have seemed minor at the time, could provide valuable diagnostic context.
One challenge is that TBI patients tend to remain primarily within neurology or rehabilitation pathways. When behavioral or psychiatric symptoms emerge, both clinicians and families may attribute these changes to the expected consequences of brain injury itself, rather than considering the possibility of a distinct psychiatric disorder. This can create what I think of as a gray zone: the patient is being treated for TBI, but an emerging psychotic disorder goes unrecognized or inadequately addressed.
Psychiatric screening should be part of routine follow-up for TBI patients, particularly those with moderate-to-severe injuries. Monitoring should also extend well beyond the acute recovery period: our data show that risk continues to rise even beyond 5 years post-injury. Additionally, both male and female TBI survivors are at elevated risk; surveillance should not be limited to male patients, as earlier literature might suggest.
PT: Can you share more on the relationship between age and psychosis after TBI?
Chu: Our subgroup analyses should be interpreted as exploratory rather than definitive, as the number of studies reporting stratified data was limited, and some subgroups were based on only 2 or 3 studies. With that caveat, several patterns emerged that I believe warrant attention.
Regarding age, adults with TBI showed a stronger association with subsequent psychosis than minors (pooled odds ratio (OR) of 2.99 versus 1.25), and this difference was statistically significant. However, even the modest elevation in minors reached significance, suggesting that TBI may elevate risk even when baseline rates of psychosis are inherently low. What concerns me clinically is the follow-up implication: psychosis typically emerges in late adolescence or early adulthood, so a child who sustains a TBI at age 10 may not manifest symptoms for another decade. Standard pediatric follow-up may not capture these delayed presentations.
PT: Was there a relationship between severity of TBI and follow-up with psychosis?
Chu: For TBI severity, we observed what appears to be a dose-response gradient. Moderate-to-severe TBI carried higher risk estimates (OR = 5.42; hazard ratio (HR) = 8.35) compared to mild TBI (OR = 3.59; HR = 4.45). The difference between groups did not reach statistical significance, so I would call this a suggestive trend. Importantly, even mild TBI—including concussion—conferred significant risk. This matters clinically because mild TBI is far more common and often goes unmonitored after the acute phase.
In our hazard ratio analyses, the pooled estimate rose from 1.58 for studies with less than one year of follow-up to 7.43 for those exceeding 5 years, and this difference was statistically significant. One might argue that longer observation simply allows more cases to accumulate, but hazard ratios inherently account for follow-up time, which suggests a genuine escalation in risk. This pattern is consistent with models of progressive neurodegeneration after TBI, including tau accumulation and hippocampal atrophy, which unfold over years.
Taken together, these patterns suggest that a one-size-fits-all approach to post-TBI psychiatric monitoring is unlikely to be sufficient. Age at injury, severity of trauma, and time since injury all appear to matter, and follow-up strategies should be tailored accordingly.
PT: How does your work highlight the need for thorough assessment of TBI and overlapping psychiatric issues?
Chu: The core message is that TBI-associated psychosis is not exclusively an acute or subacute phenomenon—it can emerge years, even decades, after the initial injury. This has direct implications for how we structure follow-up.
Psychosis tends to develop gradually. In differential diagnosis, it is often (and reasonably) considered only after more immediately life-threatening conditions have been ruled out. That is appropriate, but this reasonable hierarchy should not lead to psychotic disorders being permanently overlooked. What I believe is most needed is not a new screening tool, but a shift in awareness: clinicians managing TBI patients should keep psychosis on their radar, even when symptoms appear years after the injury and even when other explanations seem available.
There are also feasible, low-cost approaches to improving detection. Older adult patients, for example, often already undergo periodic cognitive assessments. Adding a brief psychiatric screening component to these existing assessments could help identify emerging psychotic symptoms without significantly increasing clinical burden. Additionally, TBI patients frequently move between care settings: from the emergency department to neurosurgery or neurology, to rehabilitation, and eventually to primary care. Psychiatric follow-up can easily be lost in these transitions. Building psychiatric screening into long-term TBI management as a standard component could help close this gap.
PT: Is there a proposed neurobiological basis for the relationship between TBI and psychosis/schizophrenia?
Chu: Yes, and our findings are broadly consistent with the emerging framework. The proposed mechanisms operate across multiple time scales.
In the acute phase, TBI induces diffuse axonal injury and demyelination, disrupting neuronal integrity and setting the stage for downstream pathology. In the subacute to medium-term phase, progressive damage—particularly in the temporal and parietal lobes—has been linked to deficits in cognition, emotional processing, and semantic comprehension, all of which are implicated in psychosis. Cortical thinning in prefrontal regions may further contribute to executive dysfunction. In the chronic phase, tau protein accumulation has been correlated with late-onset neuropsychiatric symptoms, and hippocampal atrophy may disrupt dopaminergic pathways, which are a core mechanism in schizophrenia.
Our finding of a time-dependent increase in risk fits this multiphase model: the rising hazard over longer follow-up periods is more consistent with progressive neurodegeneration than with a single acute insult leading to immediate psychosis.
In terms of limitations, our meta-analysis was based on clinical outcome data and could not directly assess neurobiological processes. The mechanisms I have described are a plausible framework, but direct causal evidence linking specific post-TBI neuropathology to psychosis onset remains limited.
Dr Chu is a postgraduate physician at Taipei Medical University Hospital, Taipei, Taiwan. Her research interests include neuropsychiatric outcomes following traumatic brain injury and the intersection of neurology and psychiatry.
References
1. Dewan MC, Rattani A, Gupta S, et al.
2. Chu TY, Wu CC, Xu ZX, et al.
3. Palou Martinez Y, Arrey Agbor DB, Panday P, et al.
4. Duarte DC, Duarte JC, Gonzalez AAO, et al.
